High dilution in Leukopenia treatment in five dogs
Int. j. high dilution res
; 21(2): 17-17, May 6, 2022.
Article
in En
| LILACS
| ID: biblio-1396736
Responsible library:
BR926.1
ABSTRACT
Leukopenia is associated with the consumption of peripheral leukocytes, decreasedproduction due to endotoxemia and septicemia, medullary hypoplasia, nutritional diseases orautoimmune reactions. In a case report by Narita et al, Echinacea angustifolia demonstrated theeffectiveness of treatment of leukopenia in penguins. Aims:
Report the evolution of homeopathictreatment in 5 dogs' patients between 3 and 5 years old, presenting leukopenia.Methodology:
The homeopathic treatment was chosen, using Echinaceaangustifolia due to its immunostimulant andimmunomodulatory actions, which evolution was analyzed by blood tests. The exposedinformation is consented by the tutors.Results:
The same protocol was made for all of the patients, including 4 globules of Echinacea angustifolia 6 cH orally, every 12 hours for 30 days. The first dog attended on 07/21/2021, presented 4.000 leukocytes, which increased to 6.800 on 08/17/2021. Thesecond patient attend on 12/07/2021 presented 4.700 leukocytes, increasing to 6.800 on 01/25/2022. The third patient attended on 08/24/2021 presented 5.400 leukocytes, which increased to 6.800 on 10/15/2021. The fourth patient presented 4.300 leukocytes on 01/13/2022, increasing to 5.500 on 02/11/2022. The fifth patient presented on12/12/2021 4.600 leukocytes, increasing to 8.400 on 02/03/2022. Therefore, the average of the first collection was 3.681 leukocytes and in the second there was an increase to 6.860 leukocytes (T-test, p= 0,0167).Conclusion:
The use of the homeopathic medicine Echinacea angustifolia shows great results, being a viableoption for the treatment of leukopenia, without the side effects.Key words
Full text:
1
Index:
LILACS
Main subject:
Homeopathic Therapeutics
/
Leukopenia
Type of study:
Guideline
Limits:
Animals
Language:
En
Journal:
Int. j. high dilution res
Journal subject:
HOMEOPATIA
/
Terapias Complementares
Year:
2022
Type:
Article